Cargando…
Mothers and fathers with schizophrenia: Treatment and quality of life
INTRODUCTION: Schizophrenia is a chronic disease that deteriorates the functionality of patients, especially when raising a family and caring for children. We are interested in analyzing the characteristics of mothers and fathers diagnosed with schizophrenia and their degree of global activity when...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479357/ http://dx.doi.org/10.1192/j.eurpsy.2023.2313 |
_version_ | 1785101564024717312 |
---|---|
author | Perez-Sanchez, S. Martin Herrero, I. |
author_facet | Perez-Sanchez, S. Martin Herrero, I. |
author_sort | Perez-Sanchez, S. |
collection | PubMed |
description | INTRODUCTION: Schizophrenia is a chronic disease that deteriorates the functionality of patients, especially when raising a family and caring for children. We are interested in analyzing the characteristics of mothers and fathers diagnosed with schizophrenia and their degree of global activity when switching from oral treatments to injectable treatments. OBJECTIVES: 1 To evaluate the quality of life and functional level of mothers with schizophrenia treated with quarterly paliperidone palmitate. 2. To compare the quality of life and functional level when switching from oral treatment to long-acting injectables. METHODS: Participants were 3 mothers and 3 fathers, 33-40 years old, with a diagnosis of schizophrenia in monotherapy who changed treatment with monthly paliperidone palmitate to quarterly paliperidone palmitate LD IM (525 mg/every 12 weeks). Retrospective data collection. QLS quality of life scale. RESULTS: Six patients were included, caregivers of 1 child (80%), 2 children (20%) who met the inclusion criteria and completed the questionnaires. After its application and correction by means of non-parametric tests (N<30). During oral treatment, scores are observed in the QLS questionnaire of: intrapsychic functions mean 34.2, interpersonal relationships mean 19, instrumental role mean 8, daily activities mean 8. After 12 months of treatment with intramuscular paliperidone palmitate (injectable every 12 weeks ) scores were obtained: intrapsychic functions mean 36, interpersonal relationships mean 23, instrumental role mean 15, daily activities mean 11. A better functioning of the patients was observed in the instrumental categories and daily activities. As well as the patients referred better adherence to treatment. CONCLUSIONS: In our experience, injectable long-acting Paliperidone Palmitate every 12 weeks is associated with the perception of a better quality of life in parents with schizophrenia and increases administration facilities as well as planning in their daily lives. DISCLOSURE OF INTEREST: None Declared |
format | Online Article Text |
id | pubmed-10479357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104793572023-09-06 Mothers and fathers with schizophrenia: Treatment and quality of life Perez-Sanchez, S. Martin Herrero, I. Eur Psychiatry Abstract INTRODUCTION: Schizophrenia is a chronic disease that deteriorates the functionality of patients, especially when raising a family and caring for children. We are interested in analyzing the characteristics of mothers and fathers diagnosed with schizophrenia and their degree of global activity when switching from oral treatments to injectable treatments. OBJECTIVES: 1 To evaluate the quality of life and functional level of mothers with schizophrenia treated with quarterly paliperidone palmitate. 2. To compare the quality of life and functional level when switching from oral treatment to long-acting injectables. METHODS: Participants were 3 mothers and 3 fathers, 33-40 years old, with a diagnosis of schizophrenia in monotherapy who changed treatment with monthly paliperidone palmitate to quarterly paliperidone palmitate LD IM (525 mg/every 12 weeks). Retrospective data collection. QLS quality of life scale. RESULTS: Six patients were included, caregivers of 1 child (80%), 2 children (20%) who met the inclusion criteria and completed the questionnaires. After its application and correction by means of non-parametric tests (N<30). During oral treatment, scores are observed in the QLS questionnaire of: intrapsychic functions mean 34.2, interpersonal relationships mean 19, instrumental role mean 8, daily activities mean 8. After 12 months of treatment with intramuscular paliperidone palmitate (injectable every 12 weeks ) scores were obtained: intrapsychic functions mean 36, interpersonal relationships mean 23, instrumental role mean 15, daily activities mean 11. A better functioning of the patients was observed in the instrumental categories and daily activities. As well as the patients referred better adherence to treatment. CONCLUSIONS: In our experience, injectable long-acting Paliperidone Palmitate every 12 weeks is associated with the perception of a better quality of life in parents with schizophrenia and increases administration facilities as well as planning in their daily lives. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10479357/ http://dx.doi.org/10.1192/j.eurpsy.2023.2313 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Perez-Sanchez, S. Martin Herrero, I. Mothers and fathers with schizophrenia: Treatment and quality of life |
title | Mothers and fathers with schizophrenia: Treatment and quality of life |
title_full | Mothers and fathers with schizophrenia: Treatment and quality of life |
title_fullStr | Mothers and fathers with schizophrenia: Treatment and quality of life |
title_full_unstemmed | Mothers and fathers with schizophrenia: Treatment and quality of life |
title_short | Mothers and fathers with schizophrenia: Treatment and quality of life |
title_sort | mothers and fathers with schizophrenia: treatment and quality of life |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479357/ http://dx.doi.org/10.1192/j.eurpsy.2023.2313 |
work_keys_str_mv | AT perezsanchezs mothersandfatherswithschizophreniatreatmentandqualityoflife AT martinherreroi mothersandfatherswithschizophreniatreatmentandqualityoflife |